Elderflower for Anti-Inflammatory

Research suggests that elderflower (Sambucus nigra) demonstrates meaningful anti-inflammatory activity across several laboratory-based investigations, with studies pointing to key compounds — including the flavonoids naringenin, quercetin, rutin, and kaempferol, as well as pectic polysaccharides — as likely drivers of these effects. Studies indicate that elderflower extracts and isolated constituents can suppress NF-κB activation in human skin cells, reduce nitric oxide production and pro-inflammatory signaling molecules in immune cell cultures, modulate complement system activity, and dampen inflammatory responses in macrophages. All four available studies are in vitro investigations (conducted on cells in laboratory settings), with no randomized controlled trials or human clinical studies currently represented in this body of evidence, which is an important limitation when considering the relevance of these findings to real-world use. The research is directionally consistent in supporting anti-inflammatory potential, but the absence of human trials means these findings should be regarded as preliminary and mechanistically suggestive rather than conclusive.